Summary and update on the management of differentiated thyroid cancer in 2023
Authors:
- 3 February 2024
- journal article
- review article
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 85 (2) , 110-117
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Effect of Multimodal Prehabilitation on Reducing Postoperative Complications and Enhancing Functional Capacity Following Colorectal Cancer SurgeryJAMA Surgery, 2023
- SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Synthesis and algorithmsAnnales d'Endocrinologie, 2022
- Overview of the 2022 WHO Classification of Thyroid NeoplasmsEndocrine Pathology, 2022
- Active surveillance of low-risk papillary thyroid microcarcinomaBest Practice & Research Clinical Endocrinology & Metabolism, 2022
- Temporal and geographical variations of thyroid cancer incidence and mortality in France during 1986–2015: The impact of overdiagnosisCancer Epidemiology, 2021
- Génotypage moléculaire dans les cancers réfractaires de la thyroïde en 2021 : quand, comment, et pourquoi ? Un travail du réseau TUTHYREFBulletin du Cancer, 2021
- Progression of incidence and estimate of net survival from papillary thyroid cancers diagnosed between 2008 and 2016 in FranceAnnales d'Endocrinologie, 2020
- Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysisEndocrine, 2019
- Which patient with thyroid cancer deserves systemic therapy and when?Best Practice & Research Clinical Endocrinology & Metabolism, 2017
- Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the ThyroidWorld Journal of Surgery, 2016